THYMIC EPITHELIAL CELL SUBSETS AND LINEAGE RELATIONSHIPS
胸腺上皮细胞亚群和谱系关系
基本信息
- 批准号:6163924
- 负责人:
- 金额:$ 19.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2004-02-29
- 项目状态:已结题
- 来源:
- 关键词:T lymphocyte bone marrow transplantation cell cell interaction cell differentiation cell population study cyclins cytokine receptors epithelium gene expression genetically modified animals hematopoietic growth factor insulinlike growth factor interleukin 1 interleukin 7 keratin laboratory mouse organ culture thymus thymus transplantation tumor necrosis factor alpha
项目摘要
Developmental progression of thymocytes and thymic epithelial cells
(TECs) is an interdependent process in which the maturation of each cell
type depends on reciprocal inductive interactions mediated by cellular
contact and/or soluble factors. In contrast to the extensive literature
characterizing thymocyte development, much less information is available
concerning the nature and function of TEC subsets. Given the critical
role played by TECs in T cell development, it is vitally important to
elucidate the mechanisms by which thymocytes and TECs interact in
developmental regulation. Therefore, the major objectives of this
proposal are to establish lineage relationships among TEC subsets and to
define the interactions between T cell progenitors and TECs that induce
developmental maturation of both cell types in the cortical
microenvironment. Using keratin (K) expression patterns to identify TEC
subsets we find that contrary to conventional dogma, cortical TECs are
not homogeneous, but instead contain a predominant K8+K5- subset and a
minor K8+K5+ subset. Both cortical TEC subsets are present in Rag-1-/-
and TCRbetaxdelta-/- thymi in which T-cell development is blocked at the
CD4-8-25+44- pre-T cell stage. In contrast, K8+K5+TECs predominate in
the thymi of hCD3epsilon transgenic (tg) mice in which thymocyte
development is blocked at an earlier CD4-8-25-44+ stage. Transplantation
of newborn hCD3epsilon tg thymi under the kidney capsule of Rag-1-/-
mice results in the emergence of K8+K5-TECs concomitant with the
appearance of CD25+ thymocytes. These data suggest that cortical TEC
development proceeds from a K8+K5+ precursor subset to a K8+K5- stage in
a differentiation process that depends upon T-cell lineage commitment.
We also show that the developmental window during which thymocytes
induce the formation of a normal thymic cortex in hCD3epsilon tg mice is
extended by enforced expression of a cyclin D1 transgene in TECs.
The results obtained to date suggest a plausible model for TEC
developmental progression that provides the basis for the following
testable hypotheses. (1) A primitive K8+K5+ subset located primarily at
the cortico-medullary junction contains precursor activity for
functionally distinct cortical and medullary TEC compartments. A
corollary to this hypothesis is that expression of a cyclin D1 transgene
in K8+K5+ precursors enhances TEC differentiation in response to
thymocyte influences by increasing and/or maintaining the fraction of
cycling progenitors. (2) The process of T-lineage commitment is required
to induce the differentiation and expansion of TEC precursors into two
cortical subsets by direct contact and/or elaboration of cytokines.
胸腺细胞和胸腺上皮细胞的发育进展
(TECS)是一个相互依赖的过程,在这个过程中,每个细胞的成熟
类型取决于细胞介导的互惠诱导相互作用
接触和/或溶解因素。与广泛的文献形成对比的是
关于胸腺细胞发育的特征,可用的信息要少得多
关于TEC子集的性质和功能。鉴于危急关头
TECs在T细胞发育中的作用,至关重要的是
阐明胸腺细胞和TECs相互作用的机制
发育调控。因此,这次会议的主要目标是
建议在TEC子集之间建立血统关系,并
明确T细胞祖细胞和TECs之间的相互作用
大脑皮层两种细胞类型的发育成熟
微环境。利用角蛋白(K)表达谱鉴定TEC
我们发现,与传统教条相反,大脑皮层TEC是
不是齐次的,而是包含一个主要的K8+K5子集和一个
次要K8+K5+子集。这两个皮质TEC亚群都存在于RAG-1-/-
和TCRbetax-/-胸腺,其中T细胞的发育在
CD4-8-25+44-Pre-T细胞阶段。相比之下,K8+K5+TEC在
HCD3 epsilon转基因(TG)小鼠胸腺细胞
发育受阻于较早的CD4-8-25-44+阶段。移植
RAG-1-/-肾被膜下新生hCD3epTg胸腺的表达
小鼠出现K8+K5-TECs伴随着
CD25+胸腺细胞的出现。这些数据表明,大脑皮层TEC
发展从K8+K5+前体子集发展到K8+K5-阶段
分化过程取决于T细胞谱系的承诺。
我们还表明,胸腺细胞的发育窗口
诱导hCD3 epsilon Tg小鼠正常胸腺皮质的形成
通过在TECs中强制表达Cyclin D1转基因而延伸。
到目前为止获得的结果为TEC提供了一个可信的模型
为以下方面提供基础的发展进程
可检验的假设。(1)主要位于的本原K8+K5+子集
皮质-髓质交界处含有前驱活性
功能上不同的皮质和髓质TEC隔室。一个
这一假设的必然结果是Cyclin D1转基因的表达
在K8+K5+前体促进TEC分化
胸腺细胞通过增加和/或保持
自行车赛的祖先。(2)需要T血统承诺的过程
诱导TEC前体细胞分化和扩增为两个
通过直接接触和/或阐述细胞因子而产生的皮质亚群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ellen R Richie其他文献
Ellen R Richie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ellen R Richie', 18)}}的其他基金
Project 1 - Molecular mechanisms controlling TEC dynamics and lineage hierarchies in the perinatal thymus
项目 1 - 围产期胸腺中控制 TEC 动态和谱系层次的分子机制
- 批准号:
10022937 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
Mechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus
控制围产期和成人胸腺不同生长和功能特征的机制
- 批准号:
10689271 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
Project 1 - Molecular mechanisms controlling TEC dynamics and lineage hierarchies in the perinatal thymus
项目 1 - 围产期胸腺中控制 TEC 动态和谱系层次的分子机制
- 批准号:
10689287 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
Project 1 - Molecular mechanisms controlling TEC dynamics and lineage hierarchies in the perinatal thymus
项目 1 - 围产期胸腺中控制 TEC 动态和谱系层次的分子机制
- 批准号:
10470930 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
Mechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus
控制围产期和成人胸腺不同生长和功能特征的机制
- 批准号:
10251293 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
Mechanisms controlling distinct growth and functional characteristics of the perinatal and adult thymus
控制围产期和成人胸腺不同生长和功能特征的机制
- 批准号:
10022933 - 财政年份:2020
- 资助金额:
$ 19.96万 - 项目类别:
相似海外基金
Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
- 批准号:
23K08999 - 财政年份:2023
- 资助金额:
$ 19.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
- 批准号:
10737358 - 财政年份:2023
- 资助金额:
$ 19.96万 - 项目类别:
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
- 批准号:
2889841 - 财政年份:2023
- 资助金额:
$ 19.96万 - 项目类别:
Studentship
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10722602 - 财政年份:2022
- 资助金额:
$ 19.96万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 19.96万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10600143 - 财政年份:2022
- 资助金额:
$ 19.96万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10370775 - 财政年份:2022
- 资助金额:
$ 19.96万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 19.96万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 19.96万 - 项目类别: